Sanofi India Q2 net dips 14% at Rs 73 crore
The drug firm had posted a net profit of Rs 86.1 cr in the corresponding period of FY1719-07-2017
19-07-2017
Board declares Interim Dividend
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 19, 2017, has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each for the financial year ending December 31, 2017.19-07-2017
Fixes Record Date For Interim Dividend
The Board of Directors of the Company at its Meeting held today has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each for the financial year ending 31st December 2017. The Meeting of Board of Directors commenced at 2.00 p.m. and concluded at 5.30 p.m. The Company has fixed 1st August 2017 as the record date for the purpose of payment of the Interim Dividend. The said dividend will be paid on or after 10th August 2017....19-07-2017
Board approves Dividend
The Board of Directors of the Company at its Meeting held today has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each for the financial year ending 31st December 2017. The Meeting of Board of Directors commenced at 2.00 p.m. and concluded at 5.30 p.m. The Company has fixed 1st August 2017 as the record date for the purpose of payment of the Interim Dividend. The said dividend will be paid on or after 10th August 2017....19-07-2017
Financials Results For Jun 30, 2017
We refer to our letter dated 10th July 2017 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 2.00 p.m. and concluded at 5.30 p.m. The Board approved unaudited financial results for the quarter and half year ended 30th June 2017. We enclose a copy of the unaudited financial results of the quarter and half year ended 30th June 2017 approved at this Meeting and the Limited Review Report...19-07-2017
Shareholding for the Period Ended June 30, 2017
Sanofi India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here14-07-2017
Statement Of Investor Complaints For The Quarter Ended June, 2017
Pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 please find enclosed statement of investor complaints/grievances for the quarter ended 30th June 2017.12-07-2017
Publication Of Board Meeting Notice
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal.11-07-2017
Board to consider Q2 results & Interim Dividend on July 19, 2017
Sanofi India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 19, 2017, inter alia, to consider the following:1. Unaudited financial results for the quarter and half year ended June 30, 2017 (Q2).2. Interim Dividend for the financial year ending on December 31, 2017.10-07-2017
Board Meeting On July 19, 2017
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Wednesday, 19th July 2017; inter alia to consider the following: Unaudited financial results for the quarter and half year ended 30th June 2017 (Q2). Interim Dividend for the financial year ending on 31st December 2017.10-07-2017